A detailed history of Signature Estate & Investment Advisors LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Signature Estate & Investment Advisors LLC holds 47,328 shares of ENTX stock, worth $84,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,328
Holding current value
$84,243
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$1.48 - $2.14 $70,045 - $101,281
47,328 New
47,328 $89,000

Others Institutions Holding ENTX

About Entera Bio Ltd.


  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $51.3M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Signature Estate & Investment Advisors LLC Portfolio

Follow Signature Estate & Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signature Estate & Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signature Estate & Investment Advisors LLC with notifications on news.